Skip to main content

Advertisement

Table 1 Demographics and immunological variables of the NVP-induced rash and NVP-tolerant groups

From: HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients

Variables NVP-induced rash NVP-tolerant P value
  (n = 39) (n = 60)  
Age (median IQR) 39.0 (34.0-44.0) 38.0 (35.0-41.75) *0.71
Sex [n(%)]    **0.68
   Male 22 (56.41%) 31 (51.67%)  
   Female 17 (43.59%) 29 (48.33%)  
Duration of Treatment, year (median IQR) 1 (0-3) 1 (0-2.75) *0.47
Pre-NVP-treatment CD4 T-cell count × 106/l 43.5 55 *0.71
(median IQR) (19.50-135.50) (28.25-137.50)  
Post-NVP-treatment CD4 T-cell count × 106/l 243 241 *0.98
(median IQR) (155.00-328.00) (185.00-312.25)  
  1. *Mann-Whitney U-test
  2. **Chi square test